Strategic Focus Seventure Partners is a long-term equity investor with a strong emphasis on sustainability and positive societal impact, presenting opportunities to align portfolio companies with ESG-driven selling points and impact-driven partnerships.

Life Sciences Potential The firm prioritizes life sciences, microbiome innovations, and health tech across Europe, Israel, Asia, and North America, suggesting sales opportunities in biotech tooling, digital health analytics, and microbiome-enabled solutions targeting these regions.

Funding Appetite Investment rounds range from half a million to ten million euros per round and up to twenty million euros per company, covering early to late-stage, growth, pre-IPO and IPO dynamics—useful for tailoring offer sizes and funding milestones.

Global Partnership As a subsidiary of Natixis Global Asset Management and connected to Groupe BPCE, Seventure can facilitate co-investments, cross-border deployment, and access to broader financial networks and clients.

Recent Wins Recent investments in Wultra, Mediads, Siit, Pitchy, Sekoia, and Clinical Microbiomics demonstrate active diversification across cybersecurity, ad tech, IT service management, video production software, cyber defense, and microbiome services—indicating potential for cross-sell and co-investment synergies.